Payday lenders took in $2.4 billion in fees from cash-strapped consumers in a single year, a report from the Center for ...

Growth across the Manufacturing and RMS segments is likely to have contributed to Charles River's fourth-quarter revenues.

In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Charles River Labs (CRL – Research Report) and Rezolute ...

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, ...

Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is rated as a Buy.

Upslope Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Q4 was the most challenging quarter for ...

Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against the company’s biologics license application (BLA) seeking approval of lead ...

Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...